Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | AZN | AMGN | GILD | BMY |
| Company | Adaptimmune Ther ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0666 | 203.22 | 380.00 | 148.92 | 61.70 |
| High | 0.0701 | 203.29 | 380.09 | 148.92 | 62.59 |
| Low | 0.0526 | 200.55 | 370.82 | 146.10 | 61.47 |
| Latest | 0.0549 | 201.53 | 379.27 | 148.22 | 62.33 |
| Change | -0.0098 | -0.23 | +2.27 | +0.39 | +1.11 |
| % Change | -15.15% | -0.11% | +0.60% | +0.26% | +1.81% |
| Volume | 50,777,800 | 2,911,100 | 2,028,400 | 6,925,200 | 12,345,000 |
| 20-Day Average Volume | 127,153,055 | 2,497,530 | 2,976,610 | 7,873,885 | 14,259,689 |
| Previous Close | 0.0647 | 201.76 | 377.00 | 147.83 | 61.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1355 | 201.58 | 376.01 | 150.18 | 60.79 |
| 20-Day Raw Stochastic | 5.66% | 57.64% | 75.42% | 36.13% | 91.38% |
| 20-Day Relative Strength | 40.90 | 55.54 | 59.41 | 57.04 | 64.72 |
| Weighted Alpha | -58.21 | +37.99 | +27.36 | +36.13 | +17.48 |
| Today's Opinion | 88% Sell | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.95% since 10/20/25 | -2.07% since 02/25/26 | -1.32% since 02/25/26 | +0.75% since 02/25/26 | +1.68% since 02/25/26 |
| Low | 0.0417 on 10/21/25 | 197.10 on 03/03/26 | 370.82 on 03/04/26 | 143.09 on 02/26/26 | 60.43 on 03/03/26 |
| High | 0.0926 on 10/22/25 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | -62.65% since 09/26/25 | +7.51% since 02/04/26 | +3.57% since 02/04/26 | +1.36% since 02/04/26 | +8.17% since 02/04/26 |
| Low | 0.0417 on 10/21/25 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 58.00 on 02/05/26 |
| High | 0.2750 on 10/09/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -84.17% since 07/25/25 | +11.92% since 12/04/25 | +11.50% since 12/04/25 | +20.88% since 12/04/25 | +19.98% since 12/04/25 |
| Low | 0.0403 on 09/08/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 0.2750 on 10/09/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -79.31% since 04/25/25 | +23.21% since 09/04/25 | +35.41% since 09/04/25 | +31.44% since 09/04/25 | +33.50% since 09/04/25 |
| Low | 0.0403 on 09/08/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.3578 on 07/24/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,551 | 312,911,168 | 203,228,640 | 183,519,280 | 124,672,944 |
| Shares Outstanding, K | 265,052 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 178,030,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -70,810,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 13,680,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -30,340,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.49 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/13/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/12/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.24 | 17.65 | 18.41 | 10.14 |